Tacrolimus/mycophenolate mofetil-based immunosuppression in aged kidney transplant. A prospective study
Authors:
- Ricard SolàRSRicard Solà
- Lluis GuiradoLGLluis Guirado
- Joan Manuel DíazJDJoan Manuel Díaz
- Carmen FacundoCFCarmen Facundo
- Ignasi GichIGIgnasi Gich
- Esmirna ChuyECEsmirna Chuy
- Antonio CabezasACAntonio Cabezas
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in International Immunopharmacology
- Vol. 5 (1) , 129-131
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Influence of Age on the Prognosis of Renal Transplant RecipientsAmerican Journal of Nephrology, 2001
- Immunosuppression in Elderly Renal Transplant RecipientsDrugs & Aging, 2001
- RENAL TRANSPLANT FOR RECIPIENTS OVER 60 YEARS OLDTransplantation, 2000
- Renal retransplantation in elderly recipients under tacrolimus-based immunosuppressionTransplantation Proceedings, 2000
- RENAL TRANSPLANTATION IN RECIPIENTS OVER THE AGE OF 60Transplantation, 1999
- Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profilesClinical Transplantation, 1999
- The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60Clinical Transplantation, 1997
- ???SUBOPTIMAL??? KIDNEY DONORSTransplantation, 1996